home / stock / hrow / hrow articles
Mark L Baum, Chief Executive Officer at Harrow (NASDAQ:HROW), reported a large insider buy on November 16, according to a new SEC filing. What Hap...
ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Harrow, Inc. ("Harrow" or the "Company") (NASDAQ:HR...
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Beyond Air posted a quarterly lo...
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. INVO Biosc...
U.S. stock futures traded higher this morning on Tuesday, with the Nasdaq futures gaining around 45 points this morning. Shares of The Beauty Heal...
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 10:00:07 ET Chase Knickerbocker from Craig-Hallum issued a price target of $30.00 for HROW on 2024-06-21 08:28:00. The adjusted price target was set to $30.00. At the time of the announcement, HROW was trading at $19.93. The overall price target consensus is a...
Harrow Health, Inc. (NASDAQ: HROW) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 13.77% on the day to $20.08. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an op...